Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UTI
UTI logo

UTI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Universal Technical Institute Inc (UTI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
35.740
1 Day change
0.70%
52 Week Range
40.410
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Universal Technical Institute Inc (UTI) is not a strong buy for a beginner investor seeking long-term growth. While the company shows some positive revenue growth, the significant drop in net income and EPS, coupled with bearish technical indicators and lack of positive catalysts, suggests a cautious approach. The stock may not align with the user's long-term investment goals at this time.

Technical Analysis

The MACD is bearish with a negative histogram (-0.0412) and expanding downward. RSI is neutral at 43.693, indicating no clear momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level (36.706), suggesting limited upward momentum. Key support levels are at 34.985 and 33.922, while resistance levels are at 38.427 and 39.49.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
5

Positive Catalysts

  • Revenue increased by 9.64% YoY in Q1 2026, indicating some operational growth.

Neutral/Negative Catalysts

  • Net income dropped by 42.10% YoY, EPS fell by 42.50% YoY, and gross margin slightly declined. Hedge funds are selling heavily, with a 295.72% increase in selling activity last quarter. No recent news or significant insider activity to drive positive sentiment.

Financial Performance

In Q1 2026, revenue grew to $220.84M (+9.64% YoY), but net income dropped to $12.83M (-42.10% YoY). EPS declined to $0.23 (-42.50% YoY), and gross margin slightly decreased to 49.99% (-0.58% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast UTI stock price to rise
5 Analyst Rating
Wall Street analysts forecast UTI stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 35.490
sliders
Low
36
Averages
37
High
38
Current: 35.490
sliders
Low
36
Averages
37
High
38
Barrington
Alexander Paris
Outperform
maintain
$36 -> $42
AI Analysis
2026-05-07
New
Reason
Barrington
Alexander Paris
Price Target
$36 -> $42
AI Analysis
2026-05-07
New
maintain
Outperform
Reason
Barrington analyst Alexander Paris raised the firm's price target on Universal Technical to $42 from $36 and keeps an Outperform rating on the shares. The company's fiscal Q2 report topped estimates, the analyst tells investors in a research note. The firm says that while Universal Technical's near-term investments will pressure earnings in fiscal 2026 and 2027, the company should see continued strong enrollment and earnings in 2028 and 2029.
Northland
NULL
to
Outperform
upgrade
$38 -> $41
2026-05-07
New
Reason
Northland
Price Target
$38 -> $41
2026-05-07
New
upgrade
NULL
to
Outperform
Reason
Northland raised the firm's price target on Universal Technical to $41 from $38 and keeps an Outperform rating on the shares. Underlying execution is "solid," the analyst tells investors following the company's fiscal Q2 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UTI
Unlock Now

People Also Watch